• First-line agents for treatment of nausea and vomiting in pregnancy
• Decreases likelihood of severe morning sickness
• Prevents possible progression to Hyperemesis Gravidarum
• There is no risk for birth defects or other adverse pregnancy outcomes

• Required for normal growth and cell reproduction, maintenance of erythropoiesis & for prevention of NTDs.